Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.
Several unique biological features of HIV-1 Vpr make it a potentially powerful agent for anti-cancer therapy. First, Vpr inhibits cell proliferation by induction of cell cycle G2 arrest. Second, it induces apoptosis through multiple mechanisms, which could be significant as it may be able to overcom...
Guardado en:
Autores principales: | Richard Y Zhao, Dong Liang, Ge Li, Christopher W Larrimore, Bernard L Mirkin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/38e811006a4e42b6a91be8d019a5a468 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuroblastoma
por: Fuentes,Luis, et al.
Publicado: (1976) -
Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
por: Rui M, et al.
Publicado: (2016) -
Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
por: Wenyan Zhang, et al.
Publicado: (2008) -
piR-39980 mediates doxorubicin resistance in fibrosarcoma by regulating drug accumulation and DNA repair
por: Basudeb Das, et al.
Publicado: (2021) -
An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
por: Shen M, et al.
Publicado: (2012)